The different expression and significance of methyl CpG binding protein 2 and histone deacetylase 6 in human scar formation
10.3760/cma.j.issn.1009-4598.2019.10.014
- VernacularTitle: 甲基化结合蛋白2和组蛋白去乙酰化酶6在人瘢痕组织中的表达
- Author:
Dan LI
1
;
Juan ZHAO
1
;
E YANG
1
;
Hengshu ZHANG
1
Author Information
1. Department of Plastic and Burn Surgery, First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China
- Publication Type:Journal Article
- Keywords:
Methyl CpG binding protein 2;
Histone deacetylase 6;
Scar;
Fibrosis;
Epigenetics
- From:
Chinese Journal of Plastic Surgery
2019;35(10):1019-1026
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the expression and significance of fibroblasts methyl CpG binding protein 2(MECP2)and histone deacetylase 6(HDAC6) at different stages of scar tissues and hypertrophic scars.
Methods:From August 2016 to May 2017, 118 cases of scar and 33 cases of upper eyelid lasia received from the Department of Plastic and Burn Surgery of the First Affiliated Hospital of Chongqing Medical University, Chongqing were collected, including 33 cases of normal skin (ages 34-68, 12 cases of male and 21 cases of female), 32 cases of normal scar (ages 8-68, 19 cases of male and 13 cases of female), 35 cases of keloid (ages 11-62, 11 cases of male and 24 cases of female) and 51 cases of hypertrophic scar (ages 12-58, 22 cases of male and 29 cases of female) without any treatment.The hypertrophic scar was divided into 4 groups according to the growth time: 10 cases in the 0-3 month group, 11 cases in the 4-6 month group, 13 cases in the 7-12 month group, and 17 cases in the >12 month group. Immunohistochemistry and western blot were used to detect the expressions of MECP2 and HDAC6 in tissues of each group, and real-time quantitative polymerase chain reaction gene amplification fluorescence detection technology was used to detect the expressions of MECP2mRNA and HDAC6 mRNA, and the differences between each group were compared. SPSS20.0 was used for statistical analysis of the data obtained in the experiment, and one-way ANOVAwas used to test the differences between the groups. P<0.05 was considered statistically significant.
Results:MECP2 protein is gradually expressed in normal skin (1 326.4±572.3), normal scar (2 341.4±816.2), hypertrophic scar (3 500.7±1407.6) and keloid (4 787.9±1 514.3), F=33.82, P=0.001. Similarly, the expression of MECP2mRNA in normal skin (0.82±0.43), normal scar (1v14±0.45), hypertrophic scar (1.59±0.39) and keloid (2.14±0.53) was also gradually increased, F=23.4, P=0.001. In normal skin (1 332.5±746.7) and normal scar (2 307.7±1 027.4), hypertrophic scar (4 107.4±1 223.1) and keloid, the level of HDAC6 protein expression (5 155.9±1 265.3) were significant different, F = 50.27, P=0.001.There were still statistically significant differences in HDAC6mRNA between normal skin (0.57±0.23), normal scar(1.03±0.35), hypertrophic scar (1.47±0.31) and keloid (1.87±0.45), F=38.06, P=0.001.In hypertrophic scar, there was no significant difference in MECP2 between the 0-3 month group (4 758.4±660.1) and the 4-6 month group (4 602.4 ±583.9), F=1.28, P=0.97), 7-12 month (3 000.7±982.7) group and >12 month (1 990.7 ±992.3)group of MECP2 expression quantity decrease, F=25.8, P=0.001; There was no significant difference in the level of HDAC6 protein in the 0-3 month (5 069.3±1 236.1) group and 4-6 month (5 316.7±1 237.4) group, F=1.02, P=0.98, and the expression was significantly reduced in the 7-12 month (3 084.7±1 685.5) group and the>12 month (2 304.6±1 337.1)group, F=11.41, P=0.001.
Conclusions:MECP2 and HDAC6 play a critical role in the formation of scarring in the human body. Epigenetic regulation mediated by MECP2 and HDAC6 is an important target for inhibiting scar formation.
